A citation-based method for searching scientific literature


List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
33


Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
125
22

BRCA1 and BRCA2: 1994 and beyond.
Steven A Narod, William D Foulkes. Nat Rev Cancer 2004
590
22

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
22

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
22

Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
Deborah Cragun, Andrea Doty Besharat, Courtney Lewis, Susan T Vadaparampil, Tuya Pal. J Cancer Educ 2013
12
22

Counselling framework for moderate-penetrance cancer-susceptibility mutations.
Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
156
22

Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine.
Deborah Cragun, Courtney Lewis, Lucia Camperlengo, Tuya Pal. Healthcare (Basel) 2016
5
40

Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
Alyssa Kne, Heather Zierhut, Shari Baldinger, Karen K Swenson, Pamela Mink, Patricia McCarthy Veach, Michaela L Tsai. J Genet Couns 2017
16
22

Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
L Brannon Traxler, Monique L Martin, Alice S Kerber, Cecelia A Bellcross, Barbara E Crane, Victoria Green, Roland Matthews, Nancy M Paris, Sheryl G A Gabram. Ann Surg Oncol 2014
18
22

Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
K E Caudle, C F Thorn, T E Klein, J J Swen, H L McLeod, R B Diasio, M Schwab. Clin Pharmacol Ther 2013
218
11


Breast cancer predisposition syndromes.
Deborah Hemel, Susan M Domchek. Hematol Oncol Clin North Am 2010
16
11


Hysterectomy and risk of cardiovascular disease: a population-based cohort study.
Erik Ingelsson, Cecilia Lundholm, Anna L V Johansson, Daniel Altman. Eur Heart J 2011
96
11

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
G Hornreich, U Beller, O Lavie, P Renbaum, Y Cohen, E Levy-Lahad. Gynecol Oncol 1999
65
11

Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Joseph T Rabban, Michael Barnes, Lee-May Chen, Catherine B Powell, Beth Crawford, Charles J Zaloudek. Am J Surg Pathol 2009
30
11

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Kathleen M Schmeler, Charlotte C Sun, Diane C Bodurka, Kristin G White, Pamela T Soliman, Anne R Uyei, Julie L Erlichman, Banu K Arun, Molly S Daniels, Susan A Rimes,[...]. Obstet Gynecol 2006
43
11

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.
W A Rocca, J H Bower, D M Maraganore, J E Ahlskog, B R Grossardt, M de Andrade, L J Melton. Neurology 2008
188
11

High rates of occult fallopian tube cancer diagnosed at prophylactic bilateral salpingo-oophorectomy.
Jane E Hirst, Gregory B Gard, Kirsty McIllroy, David Nevell, Michael Field. Int J Gynecol Cancer 2009
46
11


Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
72
11

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
712
11

Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations.
Kathy Qi Cai, Andres Klein-Szanto, Devarajan Karthik, Mitchell Edelson, Mary B Daly, Robert F Ozols, Henry T Lynch, Andrew K Godwin, Xiang-Xi Xu. Gynecol Oncol 2006
22
11

The long-term effects of oophorectomy on cognitive and motor aging are age dependent.
Walter A Rocca, Brandon R Grossardt, Demetrius M Maraganore. Neurodegener Dis 2008
50
11


A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
Carolyn Y Fang, Carol Cherry, Karthik Devarajan, Tianyu Li, John Malick, Mary B Daly. Gynecol Oncol 2009
63
11


5
20

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
11

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
562
11

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.
Walter A Rocca, Brandon R Grossardt, Mariza de Andrade, George D Malkasian, L Joseph Melton. Lancet Oncol 2006
329
11

Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
L Deligdisch, J Gil, H Kerner, H S Wu, D Beck, R Gershoni-Baruch. Cancer 1999
86
11

Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study.
William H Parker, Diane Feskanich, Michael S Broder, Eunice Chang, Donna Shoupe, Cynthia M Farquhar, Jonathan S Berek, JoAnn E Manson. Obstet Gynecol 2013
243
11

Ovarian surface epithelium: family history and early events in ovarian cancer.
Alice S T Wong, Nelly Auersperg. Reprod Biol Endocrinol 2003
44
11

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
R Manchanda, A Abdelraheim, M Johnson, A N Rosenthal, E Benjamin, C Brunell, M Burnell, L Side, S Gessler, E Saridogan,[...]. BJOG 2011
72
11

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
348
11

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
Victor R Grann, Judith S Jacobson, Dustin Thomason, Dawn Hershman, Daniel F Heitjan, Alfred I Neugut. J Clin Oncol 2002
107
11

Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Michael J Callahan, Christopher P Crum, Fabiola Medeiros, David W Kindelberger, Julia A Elvin, Judy E Garber, Colleen M Feltmate, Ross S Berkowitz, Michael G Muto. J Clin Oncol 2007
332
11

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Ruth Perets, Gregory A Wyant, Katherine W Muto, Jonathan G Bijron, Barish B Poole, Kenneth T Chin, Jin Yun H Chen, Anders W Ohman, Corey D Stepule, Soongu Kwak,[...]. Cancer Cell 2013
311
11

Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.
C Bethan Powell, Eric Kenley, Lee-May Chen, Beth Crawford, Jane McLennan, Charles Zaloudek, Miriam Komaromy, Mary Beattie, John Ziegler. J Clin Oncol 2005
249
11

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies.
H Salazar, A K Godwin, M B Daly, P B Laub, W M Hogan, N Rosenblum, M P Boente, H T Lynch, T C Hamilton. J Natl Cancer Inst 1996
213
11


Pros and cons of screening for BRCA mutations.
Marissa Howard-McNatt. N C Med J 2013
1
100

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation.
Kristin Anderson, Judith S Jacobson, Daniel F Heitjan, Joshua Graff Zivin, Dawn Hershman, Alfred I Neugut, Victor R Grann. Ann Intern Med 2006
117
11

Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis.
Melinda S Yates, Larissa A Meyer, Michael T Deavers, Molly S Daniels, Elizabeth R Keeler, Samuel C Mok, David M Gershenson, Karen H Lu. Cancer Prev Res (Phila) 2011
42
11

A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer.
Susan T Vadaparampil, Gwendolyn P Quinn, Brent J Small, Jessica McIntyre, Claudia Aguado Loi, Zuheily Closser, Clement K Gwede. Genet Test Mol Biomarkers 2010
21
11

Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.
Darren Mays, McKane E Sharff, Tiffani A DeMarco, Bernice Williams, Beth Beck, Vanessa B Sheppard, Beth N Peshkin, Jennifer Eng-Wong, Kenneth P Tercyak. Fam Cancer 2012
17
11

Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population.
Cecelia A Bellcross, Amy A Lemke, Laura S Pape, Angela L Tess, Lorraine T Meisner. Genet Med 2009
66
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.